Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 1218Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

REGULATORY

Regulations and guidelines governing stem cell based products: Clinical considerations

George Bobby

Year : 2011| Volume: 2| Issue : 3 | Page no: 94-99

   This article has been cited by
 
1 Human bone marrow-derived, pooled, allogeneic mesenchymal stromal cells manufactured from multiple donors at different times show comparable biological functions in vitro, and in vivo to repair limb ischemia
Charan Thej,Sudha Balasubramanian,Mathiyazhagan Rengasamy,Ankita Walvekar,Priyanka Swamynathan,Swathi Sundar Raj,Pradnya Shahani,Pradnya Siddikuzzaman,Udaykumar Kolkundkar,Raviraja N. Seetharam,Pawan Kumar Gupta,Anish S. Majumdar
Stem Cell Research & Therapy. 2021; 12(1)
[Pubmed]  [Google Scholar] [DOI]
2 High-Throughput Raman Flow Cytometry and Beyond
Julia Gala de Pablo,Matthew Lindley,Kotaro Hiramatsu,Keisuke Goda
Accounts of Chemical Research. 2021; 54(9): 2132
[Pubmed]  [Google Scholar] [DOI]
3 Challenges for Cell-Based Medicinal Products From a Pharmaceutical Product Perspective
Dhananjay Jere,Ahmad S. Sediq,Jörg Huwyler,Ilona Vollrath,Markus Kardorff,Hanns-Christian Mahler
Journal of Pharmaceutical Sciences. 2020;
[Pubmed]  [Google Scholar] [DOI]
4 Past, Present, and Future of Affinity-based Cell Separation Technologies
Kaitlyn Bacon,Ashton Lavoie,Balaji M. Rao,Michael Daniele,Stefano Menegatti
Acta Biomaterialia. 2020;
[Pubmed]  [Google Scholar] [DOI]
5 Acute toxicity analysis of Disarib, an inhibitor of BCL2
Shivangi Sharma,Kontham Kulangara Varsha,Susmita Kumari,Vidya Gopalakrishnan,Anjana Elizabeth Jose,Bibha Choudhary,Kempegowda Mantelingu,Sathees C. Raghavan
Scientific Reports. 2020; 10(1)
[Pubmed]  [Google Scholar] [DOI]
6 Regulatory considerations for developing a phase I investigational new drug application for autologous induced pluripotent stem cells -based therapy product
Balendu Shekhar Jha,Mitra Farnoodian,Kapil Bharti
STEM CELLS Translational Medicine. 2020;
[Pubmed]  [Google Scholar] [DOI]
7 Regulation of Stem Cell-Based Research in India in Comparison with the US, EU and other Asian Countries: Current Issues and Future Perspectives
Jobin Jose,Teena George,Aaron M. Thomas
Current Stem Cell Research & Therapy. 2020; 15(6): 492
[Pubmed]  [Google Scholar] [DOI]
8 Cardiac repair and the putative role of stem cells
L. Maximilian Buja
Journal of Molecular and Cellular Cardiology. 2019; 128: 96
[Pubmed]  [Google Scholar] [DOI]
9 Stem cell/cellular interventions in human spinal cord injury: Is it time to move from guidelines to regulations and legislations? Literature review and Spinal Cord Society position statement
Harvinder S. Chhabra,Kanchan Sarda,Geeta Jotwani,M. Gourie-Devi,Erkan Kaptanoglu,Susan Charlifue,S. L. Yadav,B. Mohapatra,Abhishek Srivastava,Kedar Phadke
European Spine Journal. 2019;
[Pubmed]  [Google Scholar] [DOI]
10 Reflection and observation: cell-based screening failing to detect HBV in HUMSCs derived from HBV-infected mothers underscores the importance of more stringent donor eligibility to reduce risk of transmission of infectious diseases for stem cell-based medical products
Wei Liu,Yuanyuan Xie,Tianyun Gao,Feifei Huang,Liudi Wang,Lijun Ding,Wenqing Wang,Shuo Liu,Jianwu Dai,Bin Wang
Stem Cell Research & Therapy. 2018; 9(1)
[Pubmed]  [Google Scholar] [DOI]
11 Improved Long-Term Volume Retention of Stromal Vascular Fraction Gel Grafting with Enhanced Angiogenesis and Adipogenesis
Yuteng Zhang,Junrong Cai,Tao Zhou,Yao Yao,Ziqing Dong,Feng Lu
Plastic and Reconstructive Surgery. 2018; 141(5): 676e
[Pubmed]  [Google Scholar] [DOI]
12 Considering Cell Therapy Product “Good Manufacturing Practice” Status
Patrick Bedford,Juliana Jy,Lucas Collins,Steven Keizer
Frontiers in Medicine. 2018; 5
[Pubmed]  [Google Scholar] [DOI]
13 Accreditation of Biosafe Clinical-Grade Human Embryonic Stem Cells According to Chinese Regulations
Qi Gu,Juan Wang,Lei Wang,Zheng-Xin Liu,Wan-Wan Zhu,Yuan-Qing Tan,Wei-Fang Han,Jun Wu,Chun-Jing Feng,Jin-Hui Fang,Lei Liu,Liu Wang,Wei Li,Xiao-Yang Zhao,Bao-Yang Hu,Jie Hao,Qi Zhou
Stem Cell Reports. 2017;
[Pubmed]  [Google Scholar] [DOI]
14 Clinical translation of stem cell based interventions for spinal cord injury- Are we there yet?
Harvinder S. Chhabra,Kanchan Sarda
Advanced Drug Delivery Reviews. 2017;
[Pubmed]  [Google Scholar] [DOI]
15 Stem Cell Therapy on the Internet: Information Quality and Content Analysis of English Language Web Pages Returned by Google
Douglas Meehan,Isabella Harb Bizzi,Pietro Ghezzi
Frontiers in ICT. 2017; 4
[Pubmed]  [Google Scholar] [DOI]
16 Insight on stem cell preconditioning and instructive biomaterials to enhance cell adhesion, retention, and engraftment for tissue repair
Muhammad Shafiq,Youngmee Jung,Soo Hyun Kim
Biomaterials. 2016; 90: 85
[Pubmed]  [Google Scholar] [DOI]
17 The potential impact of bone tissue engineering in the clinic
Ruchi Mishra,Tyler Bishop,Ian L Valerio,John P Fisher,David Dean
Regenerative Medicine. 2016; 11(6): 571
[Pubmed]  [Google Scholar] [DOI]
18 Microparticles to enhance delivery of drugs and growth factors into wound sites
Sanjeev Ranjan,Flavia Fontana,Hanif Ullah,Jouni Hirvonen,Hélder A Santos
Therapeutic Delivery. 2016; 7(10): 711
[Pubmed]  [Google Scholar] [DOI]
19 Evaluating the Safety of Somatic Periosteal Cells by Flow-Cytometric Analysis Monitoring the History of DNA Damage
Tomoyuki Kawase,Kazuhide Hayama,Makoto Tsuchimochi,Masaki Nagata,Kazuhiro Okuda,Hiromasa Yoshie,Douglas M. Burns,Koh Nakata
Biopreservation and Biobanking. 2016;
[Pubmed]  [Google Scholar] [DOI]
20 Endpoints in stem cell trials in ischemic heart failure
Marko Banovic,Zlatibor Loncar,Atta Behfar,Marc Vanderheyden,Branko Beleslin,Andreas Zeiher,Marco Metra,Andre Terzic,Jozef Bartunek
Stem Cell Research & Therapy. 2015; 6(1)
[Pubmed]  [Google Scholar] [DOI]
21 Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis
Marek Barczyk,Matthias Schmidt,Sabrina Mattoli
Stem Cell Reviews and Reports. 2015; 11(4): 598
[Pubmed]  [Google Scholar] [DOI]
22 X-ray and ultraviolet C irradiation–induced ?-H2AX and p53 formation in normal human periosteal cells in vitro: markers for quality control in cell therapy
Tomoyuki Kawase,Mana Kamiya,Kazuhide Hayama,Masaki Nagata,Kazuhiro Okuda,Hiromasa Yoshie,Douglas M. Burns,Makoto Tsuchimochi,Koh Nakata
Cytotherapy. 2014;
[Pubmed]  [Google Scholar] [DOI]
23 The regulatory sciences for stem cell-based medicinal products
Bao-Zhu Yuan,Junzhi Wang
Frontiers of Medicine. 2014;
[Pubmed]  [Google Scholar] [DOI]
24 Cellular reprogramming for understanding and treating human disease
Riya R. Kanherkar,Naina Bhatia-Dey,Evgeny Makarev,Antonei B. Csoka
Frontiers in Cell and Developmental Biology. 2014; 2
[Pubmed]  [Google Scholar] [DOI]
25 Stem Cells, Dot-Com
B. A. Liang,T. K. Mackey
Science Translational Medicine. 2012; 4(151): 151cm9
[Pubmed]  [Google Scholar] [DOI]
26 Peptidhydrogele für den Einsatz von Stammzellen in der regenerativen Medizin
C.A.E. Hauser,Y.E. Loo
Gynäkologische Endokrinologie. 2012; 10(4): 255
[Pubmed]  [Google Scholar] [DOI]

 

Read this article